Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Buckle up....Gonna be a wild ride
View:
Post by Letsmake1 on Feb 18, 2021 7:44am

Buckle up....Gonna be a wild ride

Here we go!!!

https://www.stockwatch.com/News/Item?bid=Z-C:MEDV-3033709&symbol=MEDV&region=C
Comment by c4063sv on Feb 18, 2021 8:07am
TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of an investor marketing campaign to increase awareness for the Company’s strong operational results and its strategic decision to enter the telehealth and remote patient monitoring market. The Company has allocated this budget for ...more  
Comment by lscfa on Feb 18, 2021 8:27am
Outrageous fees being paid for IR services
Comment by Letsmake1 on Feb 18, 2021 8:32am
My grandfather always said... You buy cheap you get cheap I love this IR decision...if you don't sell there will be plenty of us buyers to take em
Comment by lscfa on Feb 18, 2021 8:50am
February 17, 2021 - Canntab Therapeutics Limited (CSE: PILL), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engaged Independent Trading Group Inc. ("ITG") to provide market-making services to the Company. ITG will trade the Company's common shares (the "Common Shares") on the Canadian ...more  
Comment by wembley on Feb 18, 2021 9:00am
Go Back to bed.
Comment by Letsmake1 on Feb 18, 2021 9:02am
You can find IR for $500/mth just like you can find a new car for $10k but if you want a Mercedes S class you pay $150k Whats ur point?
Comment by lscfa on Feb 18, 2021 2:23pm
RYU Apparel Engages Oak Ridge Financial VANCOUVER, BC, Feb. 18, 2021 /CNW/ - RYU Apparel Inc. (TSXV: RYU) (OTCQB: RYPPF) (FWB: RYAA) ("RYU" or the "Company"), a creator of award-winning urban athletic apparel, is pleased to announce it has engaged Minneapolis based, Oak Ridge Financial, ("Oak Ridge") member of member of FINRA and SIPC, to support the company's ...more  
Comment by Sarb99 on Feb 18, 2021 3:01pm
Let's revisit both stocks in few months and see which one got value for money spent. Moving Medivolve is no easy task, go look into the history. Anytime good news comes, MEDV/QSC goes up and in few weeks Anonymous usually drive it back to the starting point by manipulating.    Just look at the last 4-5 weeks. All these press releases, added collection sites and added revenue. Did ...more  
Comment by Letsmake1 on Feb 18, 2021 8:18am
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities